Tecan Group Ltd. header image

Tecan Group Ltd.

TECN

Equity

ISIN CH0012100191 / Valor 1210019

SIX Swiss Exchange (2026-10-09)
CHF 235.00+2.44%

Tecan Group Ltd.
UMushroom community rating:

star star star star star
3.75 2 votes No rating yet
NegativeNeutralPositive

About company

Tecan Group Ltd. is a Swiss company specializing in laboratory instruments and solutions for the life sciences and healthcare sectors. The company provides a range of products and services designed to enhance the precision, reproducibility, and compliance of laboratory processes and medical procedures. Tecan's offerings include automated laboratory instruments, software solutions, and comprehensive services that support customers from the initial stages of innovation through to project implementation and ongoing operations. By focusing on scalable and reliable outcomes, Tecan plays a crucial role in advancing research and development in various scientific fields, contributing to significant advancements in healthcare and life sciences.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

55.4%1Y
-20.8%3Y
-54.0%5Y

Performance

38.6%1Y
36.2%3Y
37.6%5Y

Volatility

Market cap

3486 M

Market cap (USD)

Daily traded volume (Shares)

68,375

Daily traded volume (Shares)

1 day high/low

206.6 / 203.4

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.75

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
2.25
Society:
starstarstarstarstar
2.25
Nature:
starstarstarstarstar
1.50
Anna Trillini
Switzerland, 15 Oct 2025
star star star star star
/
Patrik Schmocker
Switzerland, 24 Mar 2025
star star star star star
.

EQUITIES OF THE SAME SECTOR

Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.69%INR 2,291.25
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.67%EUR 116.60
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%USD 16.64
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.37%USD 451.09
Fortrea Holdings Inc
Fortrea Holdings Inc Fortrea Holdings Inc Valor: 127734378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.31%USD 20.84
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 129508879
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.14%DKK 255.25
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 39.06
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.76%CHF 80.05
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%INR 790.00
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.04%USD 27.24